BTB Korea Co.,Ltd

219750 · KQ · Healthcare / Medical Instruments & Supplies

2,865.00KRW+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close2,865.00

Open2,995.00

Day Range2,820.00 – 2,995.00

52-Week Range1,502.00 – 5,765.00

Volume5.81K

Market Cap22.35B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

Beta-0.42

50-Day Avg1,684.78

200-Day Avg3,225.83

About

BTB Korea Co.,Ltd engages in wholesaling and retailing of reagents, and test equipment. The company was founded in 1994 and is headquartered in Seoul, South Korea. BTB Korea Co.,Ltd operates as a subsidiary of BNC KOREA, Inc.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOWan Gyu Choi
Employees92
Headquarters459, DongIn building, Seoul, South Korea, 05743, Korea
Websitehttps://www.donginbio.com

Leadership

Wan Gyu ChoiChief Executive Officer

Financials

Income Statement

Currency: KRW	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	5.67B	2.70B	30.14B	32.03B
Growth (%)	-	-52.41%	+1016.82%	+6.29%
Cost of Revenue	4.90B	2.83B	22.35B	25.26B
Gross Profit	767.13M	-131.29M	7.78B	6.77B
Gross Margin	13.53%	-4.87%	25.83%	21.13%
Operating Expense	8.38B	7.25B	6.80B	9.52B
Operating Income	-7.61B	-7.39B	988.00M	-2.75B
Operating Margin	-134.23%	-273.69%	3.28%	-8.58%
EBITDA	-9.26B	-6.72B	1.23B	-1.15B
EBITDA Margin	-163.37%	-249.06%	4.08%	-3.60%
Net Income	-12.78B	-9.23B	-160.68M	-3.93B
Net Income Margin	-225.45%	-341.90%	-0.53%	-12.27%
R&D	476.71M	179.11M	194.92M	717.13M
R&D as % of Total Revenue	8.41%	6.64%	0.65%	2.24%
Interest Expense	1.93B	1.92B	519.41M	461.26M
Interest Expense % of Total Revenue	33.98%	71.14%	1.72%	1.44%

Balance Sheet

Currency: KRW	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	35.08B	37.53B	42.65B	44.24B
Total Liabilities	31.91B	37.12B	14.41B	19.94B
Total Equity	3.17B	409.02M	28.24B	24.30B
Cash	561.70M	18.06B	4.35B	5.66B
Net Debt	15.98B	-	3.19B	7.34B

Cash Flow

Currency: KRW	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	1.37B	-2.24B	-521.54M	-5.97B
Capital Expenditure	266.35M	40.74M	788.88M	400.48M
Free Cash Flow	1.10B	-2.29B	-1.31B	-6.37B
FCF to OCF	80.52%	101.82%	251.26%	106.70%

Earnings

Report Date	Sep 30, 2018	Dec 31, 2018	Mar 31, 2019	Jun 30, 2019	Sep 30, 2019	Dec 31, 2019	Mar 31, 2020	Jun 30, 2020	Sep 30, 2020	Dec 31, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	-992.62	-4406.00	585.74	-1941.85	2343.30	-5732.70	-1817.02	-6449.58	-503.04	-4044.79	-2520.78	2790.02	-4078.12	-2017.64	-2995.72	-1647.66	-870.03	-1903.59	-313.27	-458.39	-1253.18	36.39	-83.04	-7.64	53.31	21.32	-59.15	-64.68	-198.06	-128.16	-218.70
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap22.35B

Enterprise Value31.02B

Trailing P/E0.00

Forward P/E0.00

Price / Sales16.52

Price / Book1.07

Revenue (TTM)1.35B

Gross Profit (TTM)-483.35M

EBITDA-8.06B

Profit Margin0.00%

Operating Margin-0.19%

Return on Equity-89.37%

Return on Assets-16.82%

Shares Outstanding13.08M

Shares Float2.44M

Beta-0.42

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Jun 25, 20261:5
Oct 23, 20245:1
Sep 25, 20240.2:1
Dec 27, 20230.25:1
Apr 14, 20230.5:1
Aug 27, 20192:1
Feb 1, 20182.6:1